Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT05928403
Recruiting Observational

Rate of Return to Sport After Total Knee Prosthesis: Comparison of Three Types of Prostheses

NCT05928403 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-06-11
Last updated
2026-01-15

Condition(s) studied

Knee Arthropathy

Investigational drug(s) / intervention(s)

total knee prosthesis

total knee prosthesis: Comparison of three cohorts on the return to sport of patients after total knee prosthesis according to the type of prosthesis

Study summary

The purpose of the study is the rate of return to sport (regardless of the sport envisaged) after a minimum of 3 years after total knee prosthesis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * First total knee prosthesis between 2018 and 2020; * Conventional alignment technique using the same surgical technique for total knee prosthesis; * Placement of a medial pivot prosthesis (Evolution®), mobile bearing (SCORE® Amplitude) or traditional cruciate retaining prosthesis (Stryker® Triathlon); * Affiliation to a social security scheme; * Patient having been informed and having given his oral non-objection Exclusion Criteria: * Bilateral total knee prosthesis; * Medical history of revision of Total Knee Prosthesis; * Articulation malformation of the lower limbs; * Having undergone revision surgery; * Inability to understand information related to the study for linguistic, psychological, cognitive reasons; * Patient under legal protection, or deprived of liberty by judicial or administrative decision.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Clinique Aguiléra Biarritz France Not Yet Recruiting
Clinique des Cèdres Cornebarrieu France Recruiting

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05928403 on ClinicalTrials.gov ↗ ← All trials in France